Immune Tolerance Network   

A clinical research consortium sponsored by NIAID

A clinical trial for lupus nephritis

CALIBRATE: A Clinical Trial for Lupus Nephritis 

CALIBRATECALIBRATE is a clinical research study testing the safety and efficacy of an investigational drug approach in lupus nephritis: treatment with rituximab (Rituxan®) and cyclophosphamide (Cytoxan®) followed by belimumab (Benlysta®).

Am I Eligible?

If you are 18+ and have been living with active proliferative lupus nephritis, you may be eligible.

Study Locations

Find the CALIBRATE clinical research centers near you.